Adepthera LLC develops endocrine-based biopharmaceuticals. Under the direction of Stanford University School of Medicine professor Dr. Sheauyu Teddy Hsu, the company seeks to develop Hsu's research on the therapeutic potential for hormones in human health, including applications in treating life-threatening cardiovascular, developmental, and metabolic diseases. The company is focusing on preclinical and clinical development of a group of novel hormonal drug candidates.
